03.04.2018 • NewsPeopleDr. Reddy'sPharma

Erez Israeli Joins Dr. Reddy’s as New Chief Operating Officer

On Apr. 2, 2018, Erez Israeli joined Indian pharmaceutical company Dr. Reddy’s as COO and global head of Generics & PSAI. Israeli, former president & CEO of Enzymotec, succeeded Abhijit Mukherjee, who retired on Mar. 31, 2018, after 15 years with the company. In his Israely, he will report to Dr. Reddy’s co-chairman & CEO, G.V. Prasad.

Before joining Enzymotec, Israeli worked for 23 years at Teva Pharmaceuticals where he has held several leadership position.

G.V. Prasad commented on the transition: “I would like to thank Abhijit for his valuable contribution to our company’s growth journey over the past fifteen years. I extend a warm welcome to Erez Israeli. Erez is an accomplished leader with a proven track record of achievement. His knowledge and experience from leading pharmaceutical businesses of scale will be valuable for our future growth.”

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.